EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 37 / Numéro 10 (Octobre 2021) Med Sci (Paris), 37 10 (2021) 873-881 Références
Contraception
Open Access
Numéro
Med Sci (Paris)
Volume 37, Numéro 10, Octobre 2021
Contraception
Page(s) 873 - 881
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2021148
Publié en ligne 14 octobre 2021
  1. Daguerre A. Les grossesses en France et en Grande-Bretagne. Un phénomène dérangeant pour les pouvoirs publics. Informations Sociales 2010; 96–102. [Google Scholar]
  2. Vilain A. Les interruptions volontaires de grossesse en 2020. Études et Résultats: Paris, DREES, 2019. [Google Scholar]
  3. Kirbas AGulerman HCDaglar KPregnancy in adolescence: is it an obstetrical risk?. J Pediatr Adolesc Gynecol 2016 ; 29 : 367–371. [CrossRef] [PubMed] [Google Scholar]
  4. Bajos NRouzaud-Cornabas MPanjo H, et al. La crise de la pilule en France : vers un nouveau modèle contraceptif ?. Population et Sociétés 2014 ; 511 [Google Scholar]
  5. True KBajos NBohet A, et al. Timing of contraceptive initiation and association with future sexual and reproductive outcomes. Hum Reprod 2014 ; 29 : 1651–1658. [CrossRef] [PubMed] [Google Scholar]
  6. Wang J, Roth A, Fang F, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 2020; 383 : 1340–8. [CrossRef] [PubMed] [Google Scholar]
  7. Steiner RJLiddon NSwartzendruber AL, et al. Long-acting reversible contraception and condom use among female us high school students: implications for sexually transmitted infection prevention. JAMA Pediatr 2016 ; 170 : 428–434. [CrossRef] [PubMed] [Google Scholar]
  8. Jousselme C, Cosquer M, Hassler C. Portraits d’adolescents. Enquête épidémiologique en mileu scolaire en 2013. Paris : Inserm, 2015. [Google Scholar]
  9. Trussell J.Contraceptive failure in the United States. Contraception. 2011 ; 83 : 397–404. [CrossRef] [PubMed] [Google Scholar]
  10. Mansour DInki PGemzell-Danielsson KEfficacy of contraceptive methods: a review of the literature. Eur J Contracept Reprod Health Care 2010 ; 15 : (suppl 2)S19–S31. [CrossRef] [PubMed] [Google Scholar]
  11. Secura GMMadden TMcNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med 2014 ; 371 : 1316–1323. [CrossRef] [PubMed] [Google Scholar]
  12. Moreau CBohet AHassoun D, et al. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010. Fertil Steril 2013 ; 100 : 451–458. [CrossRef] [PubMed] [Google Scholar]
  13. Plu-Bureau GMaitrot-Mantelet LHugon-Rodin J, et al. Hormonal contraceptives and venous thromboembolism: an epidemiological update. Best Pract Res Clin Endocrinol Metab 2013 ; 27 : 25–34. [CrossRef] [PubMed] [Google Scholar]
  14. Gallo MF, Lopez LM, Grimes DA, et al. Combination contraceptives: effects on weight. Cochrane Database Syst Rev 2014; CD003987. [PubMed] [Google Scholar]
  15. Arowojolu AO, Gallo MF, Lopez LM, et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2012; CD004425. [PubMed] [Google Scholar]
  16. Malmborg APersson EBrynhildsen J, et al. Hormonal contraception and sexual desire: a questionnaire-based study of young Swedish women. Eur J Contracept Reprod Health Care 2016 ; 21 : 158–167. [CrossRef] [PubMed] [Google Scholar]
  17. Barnett CHagemann CDinger J, et al. Fertility and combined oral contraceptives – unintended pregnancies and planned pregnancies following oral contraceptive use – results from the INAS-SCORE study. Eur J Contracept Reprod Health Care 2017 ; 22 : 17–23. [CrossRef] [PubMed] [Google Scholar]
  18. Stoddard AMXu HMadden T, et al. Fertility after intrauterine device removal: a pilot study. Eur J Contracept Reprod Health Care 2015 ; 20 : 223–230. [CrossRef] [PubMed] [Google Scholar]
  19. Morch L.S.Skovlund C.W.Hannaford P.C., et al. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med 2017 ; 377 : 2228–2239. [CrossRef] [PubMed] [Google Scholar]
  20. Iversen LFielding SLidegaard Ø, et al. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ 2018 ; 362 : k3609. [PubMed] [Google Scholar]
  21. Collaborative group on epidemiological studies on endometrialC. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. Lancet Oncol 2015 ; 16 : 1061–1070. [CrossRef] [PubMed] [Google Scholar]
  22. Barchrach L.K. Hormonal contraception and Bone health in adolescents and contraceptives. Front Endocrinol 2020; 11 : 603. [Google Scholar]
  23. Bahamondes LBahamondes VMShulman LPNon-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Hum Reprod Update 2015 ; 21 : 640–651. [CrossRef] [PubMed] [Google Scholar]
  24. Davis ARWesthoff CO’Connell K, et al. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet Gynecol 2005 ; 106 : 97–104. [CrossRef] [PubMed] [Google Scholar]
  25. Harada TMomoeda MTaketani Y, et al. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008 ; 90 : 1583–1588. [CrossRef] [PubMed] [Google Scholar]
  26. Haamid FSass AEDietrich JEHeavy menstrual bleeding in adolescents. J Pediatr Adolesc Gynecol 2017 ; 30 : 335–340. [CrossRef] [PubMed] [Google Scholar]
  27. Dokras A.Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits. Fertil Steril 2016 ; 106 : 1572–1579. [CrossRef] [PubMed] [Google Scholar]
  28. Grimes DA, Jones LB, Lopez LM, et al. Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev 2014; CD006134. [PubMed] [Google Scholar]
  29. Quint EHMenstrual and reproductive issues in adolescents with physical and developmental disabilities. Obstet Gynecol 2014 ; 124 : 367–375. [CrossRef] [PubMed] [Google Scholar]
  30. Chabbert-Buffet NMarret HAgostini A, et al. Clinical practice guidelines for contraception by the French national college og gynecologists and obstetricians. Gynecol Obstet Hum Reprod 2019 ; 48 : 441–454. [Google Scholar]
  31. Committee on A. Contraception for adolescents. Pediatrics 2014; 134 : e1244–5. [CrossRef] [PubMed] [Google Scholar]
  32. Committee on Adolescent HealthC. Committee opinion no 699: adolescent pregnancy, contraception, and sexual activity. Obstet Gynecol 2017 ; 129 : e142–e1e9. [CrossRef] [PubMed] [Google Scholar]
  33. Bahamondes MV, Bahamondes L. Intrauterine device use is safe among nulligravidas and adloescent girls. Acta Obstet Gynecol Scand 2021; 100 : 641–8. [PubMed] [Google Scholar]
  34. Modesto WBahamondes MVBahamondes LA randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Hum Reprod 2014 ; 29 : 1393–1908. [PubMed] [Google Scholar]
  35. Darney PPatel ARosen K, et al. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2009 ; 91 : 1646–1653. [PubMed] [Google Scholar]
  36. Oringanje C, Meremikwu MM, Eko H, et al. Interventions for preventing unintended pregnancies among adolescents. Cochrane Database Syst Rev 2016; 2 : CD0052. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.